Free Trial
Your $100 Credit Is Waiting! Get MarketBeat All Access Today
Lock In $149
Claim MarketBeat All Access Sale Promotion

FMC (FMC) Financials

FMC logo
$12.69 -0.07 (-0.54%)
Closing price 03:59 PM Eastern
Extended Trading
$12.75 +0.06 (+0.48%)
As of 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for FMC

Annual Income Statements for FMC

This table shows FMC's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
489 209 1,072 502 477 552 740 737 1,322 341 -2,239
Consolidated Net Income / (Loss)
499 212 1,074 512 480 552 737 742 1,321 342 -2,237
Net Income / (Loss) Continuing Operations
-213 131 -133 538 544 580 805 839 1,420 403 -2,201
Total Pre-Tax Income
-207 181 96 608 655 731 898 984 300 253 -1,887
Total Operating Income
-147 243 159 741 822 897 1,035 1,144 556 507 -1,628
Total Gross Profit
800 931 952 1,880 2,084 2,047 2,161 2,327 1,831 1,649 1,283
Total Revenue
2,491 2,539 2,531 4,285 4,610 4,642 5,045 5,802 4,487 4,246 3,467
Operating Revenue
2,491 2,539 2,531 4,285 4,610 4,642 5,045 5,802 4,487 4,246 3,467
Total Cost of Revenue
1,691 1,608 1,579 2,406 2,526 2,595 2,884 3,476 2,656 2,597 2,184
Operating Cost of Revenue
1,691 1,608 1,579 2,406 2,526 2,595 2,884 3,476 2,656 2,597 2,184
Total Operating Expenses
947 688 793 1,139 1,262 1,150 1,127 1,183 1,275 1,142 2,911
Selling, General & Admin Expense
661 435 582 790 793 730 714 775 734 645 685
Research & Development Expense
136 135 138 288 298 288 305 314 329 278 266
Restructuring Charge
150 95 73 61 171 132 108 93 212 220 1,960
Total Other Income / (Expense), net
-61 -62 -63 -133 -167 -166 -137 -160 -255 -254 -258
Interest Expense
62 64 80 135 160 151 131 152 237 236 240
Interest & Investment Income
1.30 1.10 1.00 1.50 1.90 -15 -5.60 -8.60 - - -19
Income Tax Expense
5.20 50 229 71 112 151 93 145 -1,119 -151 314
Net Income / (Loss) Discontinued Operations
711 81 1,343 -26 -63 -28 -68 -97 -99 -62 -37
Net Income / (Loss) Attributable to Noncontrolling Interest
9.50 2.60 2.60 9.40 2.80 -0.90 -2.50 5.00 -0.50 0.50 1.50
Basic Earnings per Share
$3.66 $1.56 $3.99 $3.72 $3.64 $4.26 $5.76 $5.83 $10.55 $2.73 ($17.88)
Weighted Average Basic Shares Outstanding
133.70M 133.89M 134.26M 134.41M 129.12M 129.35M 125.70M 125.11M 124.76M 124.84M 124.93M
Diluted Earnings per Share
$3.66 $1.56 $3.99 $3.69 $3.62 $4.23 $5.73 $5.81 $10.53 $2.72 ($17.88)
Weighted Average Diluted Shares Outstanding
133.70M 133.89M 134.26M 134.41M 129.12M 129.35M 125.70M 125.11M 124.76M 124.84M 124.93M
Weighted Average Basic & Diluted Shares Outstanding
133.70M 133.89M 134.26M 134.41M 129.12M 129.35M 125.70M 125.11M 124.76M 124.84M 124.93M
Cash Dividends to Common per Share
$0.66 $0.66 $0.66 $0.90 $1.64 $1.80 $1.96 $2.17 $2.32 $2.32 $1.82

Quarterly Income Statements for FMC

This table shows FMC's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders
-3.50 1,099 -2.70 295 65 -16 -16 67 -569 -1,721 -281
Consolidated Net Income / (Loss)
-3.70 1,096 -3.10 295 66 -16 -16 68 -569 -1,721 -281
Net Income / (Loss) Continuing Operations
4.60 1,154 9.40 298 67 -268 -8.60 44 -548 -1,688 -261
Total Pre-Tax Income
32 -43 8.00 -5.50 73 178 4.90 59 -466 -1,484 -149
Total Operating Income
101 18 74 62 136 235 58 126 -396 -1,417 -81
Total Gross Profit
381 436 340 398 386 525 317 406 129 431 247
Total Revenue
982 1,146 918 1,038 1,065 1,224 791 1,051 542 1,083 759
Operating Revenue
982 1,146 918 1,038 1,065 1,224 791 1,051 542 1,083 759
Total Cost of Revenue
601 710 578 640 679 700 475 644 413 652 512
Operating Cost of Revenue
601 710 578 640 679 700 475 644 413 652 512
Total Operating Expenses
280 418 266 336 251 290 259 280 525 1,848 328
Selling, General & Admin Expense
171 172 164 165 159 157 172 177 167 169 185
Research & Development Expense
81 82 61 76 69 72 69 66 63 68 66
Restructuring Charge
28 164 41 95 23 61 18 37 295 1,611 77
Total Other Income / (Expense), net
-69 -62 -66 -68 -63 -57 -53 -68 -70 -68 -68
Interest Expense
65 52 62 64 59 52 50 61 64 64 65
Other Income / (Expense), net
- - - -4.20 -4.40 - -3.20 -6.60 -5.60 - -3.40
Income Tax Expense
27 -1,197 -1.40 -304 6.00 148 14 14 82 204 112
Net Income / (Loss) Discontinued Operations
-8.30 -57 -13 -2.80 -0.90 -43 -7.00 23 -20 -33 -20
Net Income / (Loss) Attributable to Noncontrolling Interest
-0.20 -2.10 -0.40 0.10 0.60 0.20 -0.10 1.10 0.70 -0.20 0.10
Basic Earnings per Share
($0.03) $8.78 ($0.02) $2.35 $0.52 ($0.12) ($0.12) $0.53 ($4.52) ($13.77) ($2.25)
Weighted Average Basic Shares Outstanding
124.76M 124.76M 124.82M 124.82M 124.84M 124.84M 124.91M 124.91M 124.92M 124.93M 125.05M
Diluted Earnings per Share
($0.03) $8.77 ($0.02) $2.35 $0.52 ($0.13) ($0.12) $0.53 ($4.52) ($13.77) ($2.25)
Weighted Average Diluted Shares Outstanding
124.76M 124.76M 124.82M 124.82M 124.84M 124.84M 124.91M 124.91M 124.92M 124.93M 125.05M
Weighted Average Basic & Diluted Shares Outstanding
124.76M 124.76M 124.82M 124.82M 124.84M 124.84M 124.91M 124.91M 124.92M 124.93M 125.05M
Cash Dividends to Common per Share
$0.58 - $0.58 $0.58 $0.58 - $0.58 $0.58 $0.58 - $0.08

Annual Cash Flow Statements for FMC

This table details how cash moves in and out of FMC's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
-151 -16 181 -121 177 230 -52 55 -270 55 227
Net Cash From Operating Activities
-417 498 336 368 489 629 820 582 -386 671 -80
Net Cash From Continuing Operating Activities
-471 369 232 363 556 737 899 660 -300 737 -6.20
Net Income / (Loss) Continuing Operations
-213 131 -133 538 544 580 805 839 1,420 403 -2,201
Consolidated Net Income / (Loss)
499 212 538 512 480 552 737 742 1,321 342 -2,237
Net Income / (Loss) Discontinued Operations
711 81 672 -26 -63 -28 -68 -97 -99 -62 -37
Depreciation Expense
77 101 98 150 150 163 171 169 184 176 174
Non-Cash Adjustments To Reconcile Net Income
-179 -2.80 -59 90 30 -66 416 184 8.80 97 2,109
Changes in Operating Assets and Liabilities, net
-215 141 326 -415 -168 41 -493 -533 -1,913 60 -88
Net Cash From Discontinued Operating Activities
113 129 104 5.70 -67 -89 -79 -78 -86 -66 -74
Net Cash From Investing Activities
280 -137 -2,584 -131 -187 -169 -112 -266 -154 264 -100
Net Cash From Continuing Investing Activities
-1,230 -101 -2,539 -38 -196 -200 -132 -266 -154 264 -100
Purchase of Property, Plant & Equipment
-53 -91 -1,289 -132 -142 -114 -113 -142 -150 -73 -99
Acquisitions
-1,205 0.00 - - 0.00 -66 -5.20 -198 0.00 0.00 -12
Sale of Property, Plant & Equipment
- - 38 - - - 0.00 51 5.80 0.00 0.00
Divestitures
- - 1,264 20 - - - 0.00 0.00 340 0.00
Other Investing Activities, net
-40 -12 25 -14 -54 -20 -14 24 -9.80 -3.70 11
Net Cash From Financing Activities
-14 -377 2,426 -363 -124 -250 -748 -237 332 -870 386
Net Cash From Continuing Financing Activities
-14 -375 2,426 -397 -87 -250 -748 -237 332 -870 386
Repayment of Debt
-1,584 -262 -3.10 -555 -1,011 -3.00 -1,098 114 -1,200 0.00 -501
Repurchase of Common Equity
0.00 -11 - -200 -400 -50 -408 -109 -81 -2.30 -1.80
Payment of Dividends
-86 -109 89 -89 -210 -237 -247 -268 -291 -291 -305
Issuance of Debt
1,650 2.80 3,125 80 1,500 27 1,000 0.00 1,899 -577 1,210
Issuance of Common Equity
5.90 4.10 23 374 51 25 7.90 9.40 5.30 0.20 0.20
Other Financing Activities, net
- - 2.60 -6.80 -16 -12 -2.40 16 -0.80 0.00 -16
Effect of Exchange Rate Changes
- - 4.00 4.50 -0.20 1.60 -12 -23 -60 -9.70 21

Quarterly Cash Flow Statements for FMC

This table details how cash moves in and out of FMC's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents
-618 -21 115 54 -55 -59 -42 123 60 87 -194
Net Cash From Operating Activities
68 293 -164 295 141 400 -558 50 -208 637 -617
Net Cash From Continuing Operating Activities
102 318 -143 292 160 428 -545 66 -184 657 -601
Net Income / (Loss) Continuing Operations
4.60 1,154 9.40 298 67 30 -8.60 44 -548 -1,688 -261
Consolidated Net Income / (Loss)
-3.70 1,096 -3.10 295 66 -16 -16 68 -569 -1,721 -281
Net Income / (Loss) Discontinued Operations
-8.30 -57 -13 -2.80 -0.90 -46 -7.00 23 -20 -33 -20
Depreciation Expense
46 46 46 44 43 43 44 43 43 43 42
Non-Cash Adjustments To Reconcile Net Income
-40 297 -195 96 45 178 -413 246 297 1,980 -149
Changes in Operating Assets and Liabilities, net
91 -1,178 -3.10 -146 4.90 178 -167 -268 24 323 -233
Net Cash From Discontinued Operating Activities
-34 -25 -22 2.60 -18 -28 -13 -16 -24 -20 -16
Net Cash From Investing Activities
-48 -28 -24 -16 -16 320 -38 -13 -33 -15 -16
Net Cash From Continuing Investing Activities
-48 -28 -24 -16 -16 320 -38 -13 -33 -15 -16
Purchase of Property, Plant & Equipment
-33 -25 -21 -9.90 -16 -22 -32 -17 -24 -26 -17
Other Investing Activities, net
-15 14 -3.00 -6.00 -0.60 5.90 -5.80 3.70 -9.30 23 0.60
Net Cash From Financing Activities
-633 -231 306 -221 -186 -769 552 77 303 -546 442
Net Cash From Continuing Financing Activities
-633 -231 306 -221 -186 -766 552 77 303 -546 442
Repurchase of Common Equity
- - -1.70 -0.10 -0.40 2.20 -1.40 - -0.30 -0.10 -0.90
Payment of Dividends
-73 -73 -73 -73 -73 -73 -80 -74 -78 -73 -10
Issuance of Debt
- - 380 - -232 -577 635 664 -549 460 453
Issuance of Common Equity
1.30 0.10 0.00 0.20 - - 0.20 - - - 0.00
Other Financing Activities, net
- - - - - - -1.30 - - -1.80 0.00
Effect of Exchange Rate Changes
-4.40 -56 -2.20 - - - 2.20 10 -2.70 11 -3.10

Annual Balance Sheets for FMC

This table presents FMC's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
6,326 6,139 9,206 9,974 9,873 10,186 10,673 11,171 11,926 11,653 9,687
Total Current Assets
2,972 2,849 3,653 4,030 4,075 4,376 5,054 5,439 5,129 4,958 4,959
Cash & Equivalents
79 64 283 134 339 569 517 572 302 357 585
Accounts Receivable
1,851 1,693 2,044 2,144 2,231 2,330 2,584 2,871 2,703 2,903 2,062
Inventories, net
800 479 993 1,026 1,017 1,096 1,522 1,652 1,725 1,202 1,220
Prepaid Expenses
242 232 326 433 488 381 431 344 399 496 481
Other Current Nonoperating Assets
- 382 7.30 294 - - - - - 0.00 612
Plant, Property, & Equipment, net
1,016 538 1,025 757 758 772 817 850 893 850 707
Total Noncurrent Assets
2,338 2,752 4,528 5,187 5,040 5,039 4,802 4,883 5,905 5,845 4,021
Long-Term Investments
2.50 1.00 1.40 0.70 0.70 3.10 9.20 15 20 26 20
Intangible Assets
837 720 2,632 2,703 2,629 2,625 2,522 2,508 2,465 2,361 2,362
Noncurrent Deferred & Refundable Income Taxes
287 242 253 273 257 230 194 211 1,337 1,524 1,216
Other Noncurrent Operating Assets
435 455 444 383 685 712 614 561 490 428 423
Total Liabilities & Shareholders' Equity
6,326 6,139 9,206 9,974 9,873 10,186 10,673 11,171 11,926 11,653 9,687
Total Liabilities
4,418 4,146 6,499 6,764 7,311 7,202 7,529 7,770 7,493 7,145 7,588
Total Current Liabilities
1,453 1,438 2,209 2,993 2,724 2,829 3,520 3,800 3,385 3,019 3,755
Short-Term Debt
113 94 193 548 228 338 441 541 934 337 1,305
Accounts Payable
404 317 714 796 900 947 1,135 1,252 602 769 771
Accrued Expenses
594 605 764 936 961 970 1,038 1,067 1,166 1,245 991
Current Deferred Revenue
250 240 381 458 493 347 631 681 482 454 453
Current Deferred & Payable Income Tax Liabilities
20 11 99 85 62 82 65 115 124 123 24
Current Employee Benefit Liabilities
6.40 7.10 5.70 6.20 4.30 4.20 4.30 2.30 6.40 6.40 3.30
Other Current Liabilities
67 105 52 67 76 141 206 142 70 86 46
Other Current Nonoperating Liabilities
- 59 1.30 97 - - - - - 0.00 162
Total Noncurrent Liabilities
2,964 2,708 4,290 3,771 4,587 4,373 4,009 3,971 4,108 4,125 3,833
Long-Term Debt
2,036 1,799 2,993 2,145 3,031 2,930 2,732 2,733 3,024 3,028 2,770
Asset Retirement Reserve & Litigation Obligation
282 306 346 459 471 444 416 439 495 521 600
Noncurrent Deferred & Payable Income Tax Liabilities
173 130 173 331 333 350 342 322 158 86 54
Noncurrent Employee Benefit Liabilities
194 137 59 47 44 46 42 32 24 19 21
Other Noncurrent Operating Liabilities
279 268 718 743 708 604 477 445 407 471 388
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
1,908 1,993 2,707 3,210 2,561 2,984 3,144 3,401 4,433 4,509 2,099
Total Preferred & Common Equity
1,866 1,958 2,682 3,121 2,532 2,962 3,124 3,378 4,411 4,488 2,072
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
1,866 1,958 2,682 3,121 2,532 2,962 3,124 3,378 4,411 4,488 2,072
Common Stock
436 437 469 795 848 879 899 928 954 985 991
Retained Earnings
3,385 3,506 3,952 4,334 4,189 4,506 5,093 5,556 6,587 6,638 4,170
Treasury Stock
-1,498 -1,507 -1,500 -1,699 -2,093 -2,141 -2,542 -2,646 -2,724 -2,725 -2,721
Accumulated Other Comprehensive Income / (Loss)
-457 -478 -240 -309 -412 -282 -326 -460 -407 -411 -369
Noncontrolling Interest
43 35 25 89 29 22 19 23 23 21 27

Quarterly Balance Sheets for FMC

This table presents FMC's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets
11,952 10,956 11,926 11,978 12,131 12,219 11,653 11,801 12,297 12,079 9,420
Total Current Assets
6,267 5,322 5,129 5,198 5,210 5,316 4,958 5,078 5,467 5,567 4,905
Cash & Equivalents
942 324 302 418 472 417 357 315 438 498 391
Accounts Receivable
2,783 2,565 2,703 2,818 2,702 2,891 2,903 2,900 3,076 2,330 2,245
Inventories, net
2,072 1,999 1,725 1,587 1,435 1,392 1,202 1,374 1,396 1,376 1,243
Prepaid Expenses
470 435 399 375 601 616 496 488 557 537 534
Other Current Nonoperating Assets
- - - - - - - - - 827 493
Plant, Property, & Equipment, net
868 873 893 876 861 869 850 859 891 855 628
Total Noncurrent Assets
4,817 4,762 5,905 5,905 6,059 6,034 5,845 5,865 5,939 5,656 3,887
Long-Term Investments
18 19 20 20 23 25 26 26 28 23 21
Intangible Assets
2,489 2,453 2,465 2,433 2,413 2,422 2,361 2,367 2,401 2,380 2,334
Noncurrent Deferred & Refundable Income Taxes
219 209 1,337 1,375 1,664 1,621 1,524 1,527 1,550 1,457 1,096
Other Noncurrent Operating Assets
500 495 490 489 450 448 428 430 434 438 437
Total Liabilities & Shareholders' Equity
11,952 10,956 11,926 11,978 12,131 12,219 11,653 11,801 12,297 12,079 9,420
Total Liabilities
8,574 7,642 7,493 7,646 7,550 7,589 7,145 7,389 7,869 8,278 7,570
Total Current Liabilities
4,353 3,447 3,385 3,553 3,523 3,588 3,019 3,305 3,573 3,991 3,813
Short-Term Debt
1,661 1,093 934 1,311 1,153 1,043 337 976 893 1,272 1,763
Accounts Payable
1,033 663 602 589 697 803 769 802 906 734 634
Accrued Expenses
1,428 1,483 1,166 1,361 1,481 1,574 1,245 1,347 1,632 1,485 1,106
Current Deferred Revenue
3.40 1.70 482 89 0.80 0.40 454 1.80 0.00 0.00 196
Current Deferred & Payable Income Tax Liabilities
118 108 124 116 120 83 123 103 78 78 27
Current Employee Benefit Liabilities
3.50 3.50 6.40 6.40 6.40 6.40 6.40 3.00 3.00 3.00 3.30
Other Current Liabilities
106 96 70 80 64 78 86 73 62 43 37
Other Current Nonoperating Liabilities
- - - - - - - - - 377 48
Total Noncurrent Liabilities
4,222 4,195 4,108 4,093 4,027 4,000 4,125 4,084 4,296 4,287 3,756
Long-Term Debt
3,022 3,023 3,024 3,025 3,026 3,027 3,028 3,028 3,270 3,271 2,771
Asset Retirement Reserve & Litigation Obligation
431 416 495 478 466 459 521 518 523 514 579
Noncurrent Deferred & Payable Income Tax Liabilities
324 321 158 152 110 104 86 87 94 92 49
Noncurrent Employee Benefit Liabilities
30 30 24 24 24 24 19 22 22 22 18
Other Noncurrent Operating Liabilities
415 406 407 414 401 386 471 430 387 388 340
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
3,377 3,315 4,433 4,333 4,581 4,630 4,509 4,412 4,428 3,801 1,850
Total Preferred & Common Equity
3,353 3,291 4,411 4,312 4,559 4,608 4,488 4,382 4,397 3,774 1,822
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
3,353 3,291 4,411 4,312 4,559 4,608 4,488 4,382 4,397 3,774 1,822
Common Stock
941 948 954 961 974 980 985 972 978 985 991
Retained Earnings
5,637 5,561 6,587 6,512 6,734 6,726 6,638 6,549 6,543 5,901 3,879
Treasury Stock
-2,724 -2,724 -2,724 -2,725 -2,725 -2,725 -2,725 -2,724 -2,721 -2,721 -2,718
Accumulated Other Comprehensive Income / (Loss)
-501 -495 -407 -437 -424 -373 -411 -415 -404 -391 -329
Noncontrolling Interest
24 24 23 21 21 22 21 30 31 27 28

Annual Metrics And Ratios for FMC

This table displays calculated financial ratios and metrics derived from FMC's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-23.56% 1.92% -0.30% 69.30% 7.57% 0.70% 8.68% 15.01% -22.67% -5.36% -18.34%
EBITDA Growth
-113.71% 593.26% -20.71% 227.07% 8.08% 9.96% 13.76% 8.98% -43.68% -7.72% -318.88%
EBIT Growth
-135.32% 266.01% -28.13% 324.14% 9.72% 10.25% 15.34% 10.61% -51.45% -8.84% -433.46%
NOPAT Growth
-129.24% 271.44% -225.26% 397.30% 4.13% 4.35% 30.44% 5.12% 169.33% -69.20% -240.86%
Net Income Growth
54.77% -57.53% 407.42% -52.38% -6.12% 14.85% 33.65% 0.60% 78.15% -74.14% -754.98%
EPS Growth
59.83% -57.38% 407.42% -52.38% -1.90% 16.85% 35.46% 1.40% 81.24% -74.17% -757.35%
Operating Cash Flow Growth
-213.61% 219.29% -32.60% 9.81% 32.60% 28.66% 30.49% -28.98% -166.35% 273.68% -111.95%
Free Cash Flow Firm Growth
-269.17% 196.23% -317.52% 132.28% -53.92% 11.25% 59.78% -17.18% -4.50% 114.42% -11.13%
Invested Capital Growth
52.84% -31.33% 105.18% -6.13% 4.22% 3.64% 1.94% 5.15% 32.53% -7.16% -31.67%
Revenue Q/Q Growth
-23.71% 29.25% -2.17% 12.24% 2.17% -0.96% 5.46% 3.73% -9.59% 1.88% -3.91%
EBITDA Q/Q Growth
-140.10% 179.29% -20.27% 38.64% -7.07% 3.16% 11.91% 10.55% -33.53% 45.56% -840.31%
EBIT Q/Q Growth
-348.31% 284.20% -28.74% 46.78% -8.29% 3.40% 14.11% 12.26% -40.39% 74.66% -7,210.48%
NOPAT Q/Q Growth
-348.31% 145.35% -191.73% 511.31% -15.68% -1.00% 26.04% 15.52% 224.03% -94.23% -7,210.48%
Net Income Q/Q Growth
-36.05% 2,960.81% 4,432.49% -66.87% -7.23% 10.19% 23.51% 14.15% 161.58% -76.51% -320.17%
EPS Q/Q Growth
-36.01% 2,050.00% 4,432.49% -66.87% -8.59% 10.16% 21.91% 12.16% 168.62% -76.59% -321.70%
Operating Cash Flow Q/Q Growth
-973.01% 46.89% 145.25% -22.77% 3,153.13% -18.63% 46.63% 7.91% -536.57% 18.91% 74.74%
Free Cash Flow Firm Q/Q Growth
-117.05% 635.89% -314.90% 136.04% -24.26% -23.78% 55.14% 21.54% 477.57% -89.21% 36.71%
Invested Capital Q/Q Growth
-2.73% -31.14% 102.50% -6.82% -6.24% -3.60% -5.10% -4.69% 13.85% -9.29% -30.57%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
32.13% 36.68% 37.60% 43.87% 45.20% 44.09% 42.84% 40.10% 40.81% 38.83% 37.00%
EBITDA Margin
-2.80% 13.54% 10.77% 20.81% 20.90% 22.83% 23.89% 22.64% 16.49% 16.08% -41.95%
Operating Margin
-5.88% 9.58% 6.26% 17.29% 17.82% 19.32% 20.50% 19.72% 12.38% 11.93% -46.96%
EBIT Margin
-5.88% 9.58% 6.91% 17.30% 17.65% 19.32% 20.50% 19.72% 12.38% 11.93% -46.96%
Profit (Net Income) Margin
20.01% 8.34% 42.44% 11.94% 10.42% 11.88% 14.61% 12.78% 29.44% 8.05% -64.53%
Tax Burden Percent
-240.36% 117.09% 1,121.29% 84.07% 73.31% 75.44% 82.10% 75.36% 440.04% 135.29% 118.59%
Interest Burden Percent
141.57% 74.34% 54.81% 82.06% 80.52% 81.50% 86.79% 85.98% 54.03% 49.85% 115.86%
Effective Tax Rate
0.00% 27.71% 238.94% 11.64% 17.02% 20.68% 10.30% 14.76% -372.85% -59.76% 0.00%
Return on Invested Capital (ROIC)
-3.12% 5.24% -5.29% 12.06% 12.70% 12.75% 16.18% 16.42% 37.11% 10.40% -18.08%
ROIC Less NNEP Spread (ROIC-NNEP)
35.59% 7.80% 65.98% 6.26% 4.58% 7.05% 9.04% 7.65% -4.20% -3.73% -54.65%
Return on Net Nonoperating Assets (RNNOA)
31.83% 5.61% 51.00% 5.23% 3.94% 7.14% 7.88% 6.24% -3.39% -2.76% -49.64%
Return on Equity (ROE)
28.71% 10.85% 45.71% 17.29% 16.64% 19.89% 24.06% 22.66% 33.72% 7.64% -67.72%
Cash Return on Invested Capital (CROIC)
-44.92% 42.39% -74.22% 18.38% 8.57% 9.17% 14.26% 11.40% 9.14% 17.83% 19.55%
Operating Return on Assets (OROA)
-2.51% 3.90% 2.28% 7.73% 8.20% 8.94% 9.92% 10.48% 4.81% 4.30% -15.26%
Return on Assets (ROA)
8.56% 3.40% 14.00% 5.33% 4.84% 5.50% 7.07% 6.79% 11.44% 2.90% -20.97%
Return on Common Equity (ROCE)
28.08% 10.64% 45.12% 16.95% 16.30% 19.70% 23.89% 22.51% 33.53% 7.60% -67.22%
Return on Equity Simple (ROE_SIMPLE)
26.72% 10.81% 40.06% 16.39% 18.96% 18.62% 23.59% 21.95% 29.95% 7.61% 0.00%
Net Operating Profit after Tax (NOPAT)
-103 176 -220 655 682 711 928 975 2,627 809 -1,140
NOPAT Margin
-4.12% 6.92% -8.70% 15.28% 14.79% 15.32% 18.39% 16.81% 58.55% 19.06% -32.87%
Net Nonoperating Expense Percent (NNEP)
-38.71% -2.56% -71.27% 5.79% 8.11% 5.70% 7.14% 8.77% 41.32% 14.13% 36.57%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - 14.61% 31.31% 10.28% -18.46%
Cost of Revenue to Revenue
67.87% 63.32% 62.40% 56.13% 54.80% 55.91% 57.16% 59.90% 59.19% 61.17% 63.00%
SG&A Expenses to Revenue
26.52% 17.14% 22.98% 18.44% 17.20% 15.72% 14.15% 13.36% 16.37% 15.18% 19.75%
R&D to Revenue
5.46% 5.30% 5.47% 6.71% 6.47% 6.20% 6.04% 5.42% 7.33% 6.55% 7.67%
Operating Expenses to Revenue
38.01% 27.10% 31.34% 26.58% 27.38% 24.77% 22.33% 20.38% 28.43% 26.90% 83.96%
Earnings before Interest and Taxes (EBIT)
-147 243 175 741 814 897 1,035 1,144 556 507 -1,628
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-70 344 273 892 964 1,060 1,205 1,314 740 683 -1,455
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
2.42 3.39 4.19 2.85 4.65 4.67 4.21 4.34 1.71 1.35 0.84
Price to Tangible Book Value (P/TBV)
17.87 8.97 0.00 0.00 0.00 0.00 0.00 0.00 21.45 9.79 0.00
Price to Revenue (P/Rev)
1.81 2.61 4.44 2.08 2.56 2.98 2.61 2.53 1.68 1.43 0.50
Price to Earnings (P/E)
9.23 31.71 10.48 17.72 24.68 25.05 17.80 19.93 5.72 17.79 0.00
Dividend Yield
1.95% 1.33% 0.79% 1.35% 1.80% 1.69% 1.90% 1.86% 3.83% 4.77% 13.12%
Earnings Yield
10.83% 3.15% 9.55% 5.64% 4.05% 3.99% 5.62% 5.02% 17.49% 5.62% 0.00%
Enterprise Value to Invested Capital (EV/IC)
1.67 3.11 2.53 2.20 2.69 2.91 2.73 2.86 1.39 1.21 1.02
Enterprise Value to Revenue (EV/Rev)
2.66 3.35 5.59 2.69 3.20 3.57 3.14 3.00 2.50 2.14 1.51
Enterprise Value to EBITDA (EV/EBITDA)
0.00 24.70 51.92 12.95 15.29 15.62 13.13 13.23 15.15 13.29 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 34.92 80.96 15.57 18.11 18.46 15.30 15.19 20.18 17.91 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 48.31 0.00 17.63 21.61 23.27 17.06 17.82 4.27 11.21 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 17.06 42.18 31.34 30.15 26.34 19.31 29.85 0.00 13.52 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 5.97 0.00 11.56 32.02 32.35 19.36 25.67 17.34 6.54 4.24
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
1.13 0.95 1.18 0.84 1.27 1.10 1.01 0.96 0.89 0.75 1.94
Long-Term Debt to Equity
1.07 0.90 1.11 0.67 1.18 0.98 0.87 0.80 0.68 0.67 1.32
Financial Leverage
0.89 0.72 0.77 0.84 0.86 1.01 0.87 0.82 0.81 0.74 0.91
Leverage Ratio
3.36 3.20 3.27 3.24 3.44 3.62 3.40 3.34 2.95 2.64 3.23
Compound Leverage Factor
4.75 2.38 1.79 2.66 2.77 2.95 2.95 2.87 1.59 1.31 3.74
Debt to Total Capital
52.97% 48.71% 54.06% 45.62% 55.99% 52.27% 50.23% 49.05% 47.16% 42.74% 66.00%
Short-Term Debt to Total Capital
2.78% 2.42% 3.27% 9.28% 3.91% 5.41% 6.98% 8.10% 11.13% 4.28% 21.14%
Long-Term Debt to Total Capital
50.19% 46.29% 50.79% 36.34% 52.08% 46.86% 43.25% 40.95% 36.03% 38.45% 44.86%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
1.05% 0.91% 0.43% 1.51% 0.50% 0.36% 0.31% 0.34% 0.27% 0.27% 0.44%
Common Equity to Total Capital
45.98% 50.38% 45.51% 52.87% 43.51% 47.37% 49.46% 50.61% 52.57% 56.99% 33.55%
Debt to EBITDA
-30.83 5.51 11.69 3.02 3.38 3.08 2.63 2.49 5.35 4.93 -2.80
Net Debt to EBITDA
-29.67 5.32 10.64 2.87 3.03 2.54 2.20 2.05 4.91 4.37 -2.39
Long-Term Debt to EBITDA
-29.22 5.23 10.98 2.41 3.15 2.76 2.27 2.08 4.09 4.43 -1.90
Debt to NOPAT
-20.95 10.77 -14.47 4.11 4.78 4.59 3.42 3.36 1.51 4.16 -3.58
Net Debt to NOPAT
-20.16 10.40 -13.17 3.91 4.28 3.79 2.85 2.76 1.38 3.69 -3.04
Long-Term Debt to NOPAT
-19.86 10.23 -13.59 3.28 4.45 4.12 2.94 2.80 1.15 3.74 -2.43
Altman Z-Score
1.97 2.58 2.16 2.20 2.46 2.70 2.68 2.86 2.08 2.01 0.69
Noncontrolling Interest Sharing Ratio
2.19% 2.00% 1.29% 1.94% 2.05% 0.93% 0.68% 0.65% 0.58% 0.49% 0.74%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
2.04 1.98 1.65 1.35 1.50 1.55 1.44 1.43 1.52 1.64 1.32
Quick Ratio
1.33 1.22 1.05 0.76 0.94 1.02 0.88 0.91 0.89 1.08 0.70
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-1,477 1,422 -3,092 998 460 512 818 677 647 1,387 1,232
Operating Cash Flow to CapEx
-781.46% 545.83% 26.84% 280.15% 344.26% 549.39% 727.04% 634.42% -301.64% 988.37% -81.17%
Free Cash Flow to Firm to Interest Expense
-23.75 22.39 -38.65 7.42 2.87 3.38 6.24 4.46 2.73 5.88 5.14
Operating Cash Flow to Interest Expense
-6.71 7.84 4.19 2.74 3.05 4.15 6.26 3.84 -1.63 2.85 -0.33
Operating Cash Flow Less CapEx to Interest Expense
-7.57 6.40 -11.43 1.76 2.16 3.40 5.40 3.23 -2.17 2.56 -0.75
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.43 0.41 0.33 0.45 0.46 0.46 0.48 0.53 0.39 0.36 0.33
Accounts Receivable Turnover
1.44 1.43 1.36 2.05 2.11 2.04 2.05 2.13 1.61 1.51 1.40
Inventory Turnover
2.40 2.51 2.15 2.38 2.47 2.46 2.20 2.19 1.57 1.78 1.80
Fixed Asset Turnover
2.56 3.27 3.24 4.81 6.09 6.07 6.35 6.96 5.15 4.87 4.45
Accounts Payable Turnover
4.32 4.46 3.06 3.19 2.98 2.81 2.77 2.91 2.86 3.79 2.84
Days Sales Outstanding (DSO)
253.05 254.74 269.37 178.33 173.20 179.33 177.75 171.58 226.75 240.97 261.33
Days Inventory Outstanding (DIO)
151.97 145.20 170.02 153.10 147.56 148.55 165.64 166.64 232.00 205.62 202.28
Days Payable Outstanding (DPO)
84.41 81.85 119.20 114.54 122.50 129.86 131.73 125.35 127.44 96.33 128.62
Cash Conversion Cycle (CCC)
320.61 318.09 320.19 216.89 198.27 198.02 211.66 212.87 331.31 350.25 335.00
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
3,976 2,730 5,602 5,259 5,480 5,680 5,790 6,088 8,069 7,491 5,119
Invested Capital Turnover
0.76 0.76 0.61 0.79 0.86 0.83 0.88 0.98 0.63 0.55 0.55
Increase / (Decrease) in Invested Capital
1,375 -1,246 2,872 -344 222 200 110 298 1,980 -578 -2,372
Enterprise Value (EV)
6,625 8,493 14,153 11,545 14,730 16,555 15,832 17,386 11,212 9,072 5,230
Market Capitalization
4,514 6,630 11,226 8,898 11,782 13,837 13,167 14,675 7,555 6,068 1,733
Book Value per Share
$13.96 $14.63 $19.97 $23.18 $19.54 $22.83 $24.65 $26.82 $35.36 $35.95 $16.58
Tangible Book Value per Share
$1.89 $5.52 ($8.56) ($7.80) ($12.07) ($8.73) ($6.79) ($5.71) $2.82 $4.96 ($2.32)
Total Capital
4,057 3,886 5,893 5,903 5,820 6,252 6,316 6,675 8,391 7,874 6,174
Total Debt
2,149 1,893 3,186 2,693 3,259 3,268 3,173 3,274 3,958 3,365 4,075
Total Long-Term Debt
2,036 1,799 2,993 2,145 3,031 2,930 2,732 2,733 3,024 3,028 2,770
Net Debt
2,068 1,828 2,901 2,558 2,919 2,696 2,647 2,688 3,635 2,982 3,470
Capital Expenditures (CapEx)
53 91 1,250 132 142 114 113 92 128 68 99
Debt-free, Cash-free Net Working Capital (DFCFNWC)
1,553 1,441 1,353 1,450 1,240 1,316 1,458 1,608 2,376 1,919 1,924
Debt-free Net Working Capital (DFNWC)
1,631 1,505 1,636 1,585 1,579 1,885 1,974 2,180 2,679 2,277 2,509
Net Working Capital (NWC)
1,519 1,411 1,443 1,037 1,351 1,547 1,534 1,639 1,745 1,939 1,204
Net Nonoperating Expense (NNE)
-601 -36 -1,294 143 202 160 191 234 1,306 468 1,098
Net Nonoperating Obligations (NNO)
2,068 737 2,895 2,048 2,919 2,696 2,647 2,688 3,635 2,982 3,020
Total Depreciation and Amortization (D&A)
77 101 98 150 150 163 171 169 184 176 174
Debt-free, Cash-free Net Working Capital to Revenue
62.33% 56.76% 53.45% 33.84% 26.89% 28.35% 28.89% 27.71% 52.96% 45.20% 55.50%
Debt-free Net Working Capital to Revenue
65.48% 59.29% 64.63% 36.98% 34.24% 40.60% 39.13% 37.57% 59.70% 53.61% 72.35%
Net Working Capital to Revenue
60.96% 55.58% 57.02% 24.19% 29.31% 33.32% 30.40% 28.25% 38.88% 45.67% 34.71%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 $0.00 $0.00 $3.64 $4.24 $5.72 $0.00 $10.55 $2.73 ($17.88)
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 0.00 0.00 129.12M 129.35M 125.70M 0.00 124.76M 124.84M 124.93M
Adjusted Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $3.62 $4.22 $5.70 $0.00 $10.53 $2.72 ($17.88)
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 0.00 0.00 129.12M 129.35M 125.70M 0.00 124.76M 124.84M 124.93M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 0.00 0.00 129.12M 129.35M 125.70M 0.00 124.76M 124.84M 124.93M
Normalized Net Operating Profit after Tax (NOPAT)
2.66 244 162 709 824 816 1,025 1,055 538 508 232
Normalized NOPAT Margin
0.11% 9.63% 6.41% 16.54% 17.87% 17.58% 20.31% 18.18% 11.98% 11.97% 6.70%
Pre Tax Income Margin
-8.33% 7.12% 3.78% 14.20% 14.21% 15.75% 17.80% 16.96% 6.69% 5.95% -54.41%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
-2.36 3.83 2.19 5.51 5.07 5.93 7.89 7.54 2.34 2.15 -6.80
NOPAT to Interest Expense
-1.65 2.77 -2.75 4.87 4.25 4.70 7.08 6.43 11.08 3.43 -4.76
EBIT Less CapEx to Interest Expense
-3.21 2.39 -13.44 4.53 4.19 5.17 7.03 6.93 1.80 1.86 -7.21
NOPAT Less CapEx to Interest Expense
-2.51 1.33 -18.38 3.89 3.37 3.95 6.22 5.82 10.54 3.14 -5.17
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
17.33% 51.30% -8.31% 17.44% 43.79% 43.01% 33.54% 36.14% 22.04% 85.28% -13.63%
Augmented Payout Ratio
17.33% 56.59% -8.31% 56.54% 127.09% 52.08% 88.89% 50.83% 28.18% 85.28% -13.71%

Quarterly Metrics And Ratios for FMC

This table displays calculated financial ratios and metrics derived from FMC's official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding
- - - - - - - - - - 125,045,301.00
DEI Adjusted Shares Outstanding
- - - - - - - - - - 125,045,301.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - - -2.25
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-28.70% -29.34% -31.71% 2.36% 8.50% 6.82% -13.79% 1.17% -49.11% -11.52% -4.14%
EBITDA Growth
-41.90% -85.36% -65.72% -40.88% 22.13% 333.91% -14.87% 59.38% -305.56% -594.60% -142.96%
EBIT Growth
-52.14% -95.41% -75.70% -52.87% 34.52% 1,196.13% -21.35% 106.20% -406.33% -703.84% -253.45%
NOPAT Growth
-91.28% -96.67% -65.79% -61.38% 758.37% 207.73% -217.48% 118.86% -323.04% -2,643.28% 44.49%
Net Income Growth
-103.13% 291.01% -101.58% 811.11% 1,872.97% -101.47% -403.23% -77.03% -966.77% -10,589.44% -1,702.56%
EPS Growth
-103.16% 306.02% -101.29% 879.17% 1,833.33% -101.48% -500.00% -77.45% -969.23% -10,492.31% -1,775.00%
Operating Cash Flow Growth
-83.01% -52.66% 80.97% 151.54% 109.19% 36.44% -239.60% -83.21% -247.45% 59.40% -10.44%
Free Cash Flow Firm Growth
-465.23% -2,486.46% -105.73% -94.95% -52.95% 131.34% 105.78% 121.00% 158.10% 123.92% 4,440.13%
Invested Capital Growth
10.94% 32.53% 14.39% 16.41% 16.52% -7.16% -1.91% -1.69% -10.72% -31.67% -31.55%
Revenue Q/Q Growth
-3.21% 16.72% -19.90% 13.12% 2.60% 14.91% -35.36% 32.74% -48.39% 99.80% -29.97%
EBITDA Q/Q Growth
-18.80% -56.28% 87.03% -10.94% 67.73% 55.31% -63.31% 60.16% -319.67% -283.12% 96.91%
EBIT Q/Q Growth
-23.75% -82.04% 308.84% -15.81% 117.66% 73.01% -75.19% 105.84% -435.48% -252.48% 94.04%
NOPAT Q/Q Growth
-87.17% -12.56% 586.27% -49.84% 185.21% -68.65% -361.98% 193.44% -390.65% -257.46% 94.28%
Net Income Q/Q Growth
-111.42% 29,732.43% -100.28% 9,622.58% -77.78% -124.54% 3.11% 534.62% -938.64% -202.67% 83.66%
EPS Q/Q Growth
-112.50% 29,333.33% -100.23% 11,850.00% -77.87% -125.00% 7.69% 541.67% -952.83% -204.65% 83.66%
Operating Cash Flow Q/Q Growth
-42.41% 333.78% -156.15% 279.32% -52.10% 182.93% -239.75% 108.87% -520.61% 405.86% -196.83%
Free Cash Flow Firm Q/Q Growth
-18.97% -187.55% 51.78% -18.19% 6.66% 158.91% -91.10% 329.23% 158.27% 127.05% 80.37%
Invested Capital Q/Q Growth
-0.19% 13.85% 2.01% 0.42% -0.09% -9.29% 7.78% 0.64% -9.27% -30.57% 7.96%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
38.82% 38.02% 37.00% 38.34% 36.27% 42.86% 40.02% 38.68% 23.77% 39.80% 32.51%
EBITDA Margin
14.91% 5.58% 13.04% 10.27% 16.78% 22.68% 12.88% 15.54% -66.12% -126.79% -5.59%
Operating Margin
10.27% 1.58% 8.06% 6.00% 12.73% 19.16% 7.35% 12.03% -73.09% -130.77% -10.68%
EBIT Margin
10.27% 1.58% 8.06% 6.00% 12.73% 19.16% 7.35% 11.40% -74.12% -130.77% -11.13%
Profit (Net Income) Margin
-0.38% 95.66% -0.34% 28.43% 6.16% -1.32% -1.97% 6.45% -104.87% -158.87% -37.07%
Tax Burden Percent
-11.56% -2,526.27% -38.75% -5,367.27% 90.48% -9.07% -318.37% 115.31% 122.02% 115.95% 188.47%
Interest Burden Percent
31.75% -239.78% 10.81% -8.83% 53.47% 75.66% 8.42% 49.08% 115.95% 104.78% 176.78%
Effective Tax Rate
85.63% 0.00% -17.50% 0.00% 8.28% 83.38% 275.51% 24.49% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
1.09% 0.70% 4.99% 2.23% 6.34% 1.74% -6.52% 4.58% -23.62% -50.34% -3.78%
ROIC Less NNEP Spread (ROIC-NNEP)
0.56% 34.98% 2.62% 9.03% 4.75% 0.07% -4.23% 3.83% -31.71% -74.64% -9.89%
Return on Net Nonoperating Assets (RNNOA)
0.60% 28.23% 2.54% 8.40% 4.43% 0.05% -3.66% 3.14% -27.08% -67.81% -11.60%
Return on Equity (ROE)
1.69% 28.93% 7.53% 10.63% 10.77% 1.79% -10.18% 7.72% -50.70% -118.15% -15.37%
Cash Return on Invested Capital (CROIC)
1.66% 9.14% 72.81% -12.84% 167.44% 17.83% 11.23% 4.55% 11.54% 19.55% 19.26%
Operating Return on Assets (OROA)
4.69% 0.61% 2.76% 2.04% 4.58% 6.90% 2.55% 3.86% -22.02% -42.49% -3.60%
Return on Assets (ROA)
-0.17% 37.17% -0.12% 9.64% 2.21% -0.47% -0.68% 2.18% -31.15% -51.63% -12.00%
Return on Common Equity (ROCE)
1.68% 28.76% 7.48% 10.57% 10.71% 1.78% -10.12% 7.68% -50.41% -117.27% -15.23%
Return on Equity Simple (ROE_SIMPLE)
15.35% 0.00% 26.02% 30.37% 31.56% 0.00% 7.51% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
14 13 87 44 124 39 -102 95 -277 -992 -57
NOPAT Margin
1.48% 1.11% 9.47% 4.20% 11.67% 3.18% -12.91% 9.09% -51.16% -91.54% -7.47%
Net Nonoperating Expense Percent (NNEP)
0.52% -34.28% 2.37% -6.79% 1.59% 1.66% -2.29% 0.75% 8.09% 24.30% 6.12%
Return On Investment Capital (ROIC_SIMPLE)
- 0.15% - - - 0.50% -1.21% 1.11% -3.33% -16.06% -0.89%
Cost of Revenue to Revenue
61.18% 61.98% 63.00% 61.66% 63.73% 57.14% 59.98% 61.32% 76.23% 60.20% 67.49%
SG&A Expenses to Revenue
17.45% 14.96% 17.85% 15.87% 14.94% 12.80% 21.73% 16.83% 30.87% 15.57% 24.40%
R&D to Revenue
8.24% 7.14% 6.63% 7.31% 6.48% 5.90% 8.68% 6.32% 11.67% 6.25% 8.63%
Operating Expenses to Revenue
28.56% 36.44% 28.94% 32.34% 23.54% 23.70% 32.66% 26.64% 96.86% 170.56% 43.18%
Earnings before Interest and Taxes (EBIT)
101 18 74 62 136 235 58 120 -402 -1,417 -84
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
146 64 120 107 179 278 102 163 -359 -1,374 -42
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
2.44 1.71 1.84 1.58 1.79 1.35 1.20 1.19 1.11 0.84 1.18
Price to Tangible Book Value (P/TBV)
0.00 21.45 27.34 11.28 12.32 9.79 10.53 11.13 121.06 0.00 0.00
Price to Revenue (P/Rev)
1.62 1.68 1.96 1.76 1.97 1.43 1.28 1.26 1.16 0.50 0.63
Price to Earnings (P/E)
16.19 5.72 7.08 5.18 5.65 17.79 16.04 52.20 0.00 0.00 0.00
Dividend Yield
3.60% 3.83% 3.64% 4.03% 3.52% 4.77% 5.50% 5.56% 6.90% 13.12% 7.67%
Earnings Yield
6.18% 17.49% 14.13% 19.31% 17.69% 5.62% 6.23% 1.92% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
1.67 1.39 1.44 1.32 1.44 1.21 1.11 1.10 1.12 1.02 1.14
Enterprise Value to Revenue (EV/Rev)
2.39 2.50 2.92 2.67 2.85 2.14 2.17 2.16 2.29 1.51 1.83
Enterprise Value to EBITDA (EV/EBITDA)
10.64 15.15 23.25 24.94 25.33 13.29 13.47 12.28 41.98 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
12.71 20.18 36.50 42.67 40.97 17.91 18.26 16.12 360.24 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
14.61 4.27 1.78 60.96 0.85 11.21 11.81 38.37 514.63 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 37.90 22.19 21.05 13.52 32.32 280.36 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
105.75 17.34 2.11 0.00 0.92 6.54 9.79 23.97 9.15 4.24 4.81
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
1.24 0.89 1.00 0.91 0.88 0.75 0.91 0.94 1.20 1.94 2.45
Long-Term Debt to Equity
0.91 0.68 0.70 0.66 0.65 0.67 0.69 0.74 0.86 1.32 1.50
Financial Leverage
1.07 0.81 0.97 0.93 0.93 0.74 0.86 0.82 0.85 0.91 1.17
Leverage Ratio
3.33 2.95 3.03 3.03 2.92 2.64 2.72 2.71 2.88 3.23 3.39
Compound Leverage Factor
1.06 -7.07 0.33 -0.27 1.56 2.00 0.23 1.33 3.34 3.38 5.99
Debt to Total Capital
55.39% 47.16% 50.02% 47.71% 46.78% 42.74% 47.58% 48.46% 54.44% 66.00% 71.02%
Short-Term Debt to Total Capital
14.71% 11.13% 15.12% 13.17% 11.99% 4.28% 11.60% 10.40% 15.24% 21.14% 27.62%
Long-Term Debt to Total Capital
40.68% 36.03% 34.89% 34.54% 34.79% 38.45% 35.98% 38.06% 39.20% 44.86% 43.40%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.32% 0.27% 0.25% 0.24% 0.26% 0.27% 0.35% 0.36% 0.32% 0.44% 0.44%
Common Equity to Total Capital
44.29% 52.57% 49.74% 52.05% 52.96% 56.99% 52.07% 51.18% 45.23% 33.55% 28.54%
Debt to EBITDA
3.70 5.35 8.49 9.57 8.68 4.93 6.02 5.72 23.12 -2.80 -2.84
Net Debt to EBITDA
3.39 4.91 7.64 8.44 7.73 4.37 5.51 5.08 20.47 -2.39 -2.58
Long-Term Debt to EBITDA
2.72 4.09 5.93 6.93 6.45 4.43 4.55 4.49 16.64 -1.90 -1.74
Debt to NOPAT
5.08 1.51 0.65 23.39 0.29 4.16 5.28 17.86 283.36 -3.58 -3.66
Net Debt to NOPAT
4.65 1.38 0.59 20.63 0.26 3.69 4.83 15.86 250.89 -3.04 -3.33
Long-Term Debt to NOPAT
3.73 1.15 0.45 16.94 0.22 3.74 3.99 14.03 204.02 -2.43 -2.24
Altman Z-Score
2.03 1.93 1.91 1.87 1.97 1.94 1.75 1.70 1.33 0.76 1.22
Noncontrolling Interest Sharing Ratio
0.60% 0.58% 0.58% 0.57% 0.58% 0.49% 0.58% 0.58% 0.58% 0.74% 0.92%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.54 1.52 1.46 1.48 1.48 1.64 1.54 1.53 1.40 1.32 1.29
Quick Ratio
0.84 0.89 0.91 0.90 0.92 1.08 0.97 0.98 0.71 0.70 0.69
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-684 -1,968 -949 -1,121 -1,047 617 55 235 608 1,381 2,490
Operating Cash Flow to CapEx
204.55% 1,166.53% -794.20% 2,977.78% 899.36% 1,849.54% -1,766.77% 289.47% -878.48% 2,412.12% -3,670.24%
Free Cash Flow to Firm to Interest Expense
-10.59 -37.77 -15.38 -17.63 -17.83 11.90 1.09 3.86 9.49 21.44 38.43
Operating Cash Flow to Interest Expense
1.04 5.62 -2.66 4.64 2.41 7.71 -11.14 0.81 -3.25 9.89 -9.52
Operating Cash Flow Less CapEx to Interest Expense
0.53 5.14 -3.00 4.48 2.14 7.30 -11.77 0.53 -3.62 9.48 -9.77
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.46 0.39 0.34 0.34 0.36 0.36 0.35 0.34 0.30 0.33 0.32
Accounts Receivable Turnover
1.92 1.61 1.35 1.49 1.53 1.51 1.44 1.43 1.38 1.40 1.34
Inventory Turnover
1.55 1.57 1.41 1.44 1.54 1.78 1.68 1.76 1.61 1.80 1.70
Fixed Asset Turnover
5.97 5.15 4.67 4.72 4.79 4.87 4.75 4.72 4.18 4.45 4.62
Accounts Payable Turnover
3.37 2.86 2.79 2.92 3.56 3.79 3.59 3.12 2.91 2.84 3.09
Days Sales Outstanding (DSO)
189.92 226.75 270.57 245.09 238.86 240.97 253.32 255.26 264.04 261.33 273.38
Days Inventory Outstanding (DIO)
236.22 232.00 258.34 253.03 237.27 205.62 216.74 206.85 226.35 202.28 214.97
Days Payable Outstanding (DPO)
108.18 127.44 130.88 124.81 102.54 96.33 101.81 117.16 125.64 128.62 117.95
Cash Conversion Cycle (CCC)
317.96 331.31 398.03 373.31 373.59 350.25 368.25 344.95 364.74 335.00 370.40
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
7,087 8,069 8,231 8,266 8,258 7,491 8,074 8,126 7,373 5,119 5,527
Invested Capital Turnover
0.74 0.63 0.53 0.53 0.54 0.55 0.51 0.50 0.46 0.55 0.51
Increase / (Decrease) in Invested Capital
699 1,980 1,036 1,165 1,171 -578 -157 -140 -886 -2,372 -2,547
Enterprise Value (EV)
11,842 11,212 11,866 10,889 11,881 9,072 8,959 8,943 8,250 5,230 6,301
Market Capitalization
8,046 7,555 7,947 7,183 8,231 6,068 5,267 5,215 4,201 1,733 2,151
Book Value per Share
$26.38 $35.36 $34.54 $36.53 $36.91 $35.95 $35.10 $35.20 $30.21 $16.58 $14.58
Tangible Book Value per Share
($5.99) $2.82 $2.33 $5.10 $5.35 $4.96 $4.01 $3.75 $0.28 ($2.32) ($4.09)
Total Capital
7,430 8,391 8,669 8,760 8,700 7,874 8,415 8,591 8,343 6,174 6,384
Total Debt
4,116 3,958 4,336 4,179 4,070 3,365 4,004 4,163 4,542 4,075 4,534
Total Long-Term Debt
3,023 3,024 3,025 3,026 3,027 3,028 3,028 3,270 3,271 2,770 2,771
Net Debt
3,773 3,635 3,898 3,685 3,628 2,982 3,662 3,697 4,022 3,470 4,122
Capital Expenditures (CapEx)
33 25 21 9.90 16 22 32 17 24 26 17
Debt-free, Cash-free Net Working Capital (DFCFNWC)
2,645 2,376 2,538 2,369 2,354 1,919 2,433 2,349 2,351 1,924 2,464
Debt-free Net Working Capital (DFNWC)
2,969 2,679 2,956 2,840 2,770 2,277 2,748 2,788 2,848 2,509 2,855
Net Working Capital (NWC)
1,876 1,745 1,645 1,687 1,727 1,939 1,772 1,894 1,577 1,204 1,092
Net Nonoperating Expense (NNE)
18 -1,084 90 -252 59 55 -87 28 291 729 225
Net Nonoperating Obligations (NNO)
3,773 3,635 3,898 3,685 3,628 2,982 3,662 3,697 3,572 3,020 3,677
Total Depreciation and Amortization (D&A)
46 46 46 44 43 43 44 43 43 43 42
Debt-free, Cash-free Net Working Capital to Revenue
53.29% 52.96% 62.51% 58.00% 56.47% 45.20% 59.06% 56.86% 65.15% 55.50% 71.73%
Debt-free Net Working Capital to Revenue
59.82% 59.70% 72.80% 69.54% 66.47% 53.61% 66.71% 67.47% 78.94% 72.35% 83.11%
Net Working Capital to Revenue
37.80% 38.88% 40.51% 41.31% 41.44% 45.67% 43.02% 45.85% 43.70% 34.71% 31.78%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($0.03) $8.78 ($0.02) $2.35 $0.52 ($0.12) ($0.12) $0.53 ($4.52) ($13.77) ($2.25)
Adjusted Weighted Average Basic Shares Outstanding
124.76M 124.76M 124.82M 124.82M 124.84M 124.84M 124.91M 124.91M 124.92M 124.93M 125.05M
Adjusted Diluted Earnings per Share
($0.03) $8.77 ($0.02) $2.35 $0.52 ($0.13) ($0.12) $0.53 ($4.52) ($13.77) ($2.25)
Adjusted Weighted Average Diluted Shares Outstanding
124.76M 124.76M 124.82M 124.82M 124.84M 124.84M 124.91M 124.91M 124.92M 124.93M 125.05M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
124.76M 124.76M 124.82M 124.82M 124.84M 124.84M 124.91M 124.91M 124.92M 124.93M 125.05M
Normalized Net Operating Profit after Tax (NOPAT)
90 128 80 110 145 207 53 123 -71 136 -2.80
Normalized NOPAT Margin
9.20% 11.14% 8.76% 10.61% 13.62% 16.91% 6.72% 11.72% -13.14% 12.58% -0.37%
Pre Tax Income Margin
3.26% -3.79% 0.87% -0.53% 6.81% 14.50% 0.62% 5.60% -85.95% -137.02% -19.67%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
1.56 0.35 1.20 0.98 2.31 4.53 1.16 1.96 -6.27 -22.00 -1.30
NOPAT to Interest Expense
0.22 0.24 1.41 0.69 2.12 0.75 -2.04 1.56 -4.33 -15.40 -0.88
EBIT Less CapEx to Interest Expense
1.05 -0.13 0.86 0.82 2.04 4.11 0.53 1.68 -6.64 -22.41 -1.56
NOPAT Less CapEx to Interest Expense
-0.29 -0.24 1.07 0.53 1.85 0.34 -2.67 1.28 -4.70 -15.81 -1.13
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
56.61% 22.04% 25.93% 21.01% 20.03% 85.28% 90.88% 295.18% -57.22% -13.63% -9.37%
Augmented Payout Ratio
92.50% 28.18% 30.58% 21.14% 20.18% 85.28% 90.79% 294.79% -57.13% -13.71% -9.42%

Financials Breakdown Chart

Key Financial Trends

Here is a concise, four-year view of FMC (NYSE:FMC) using quarterly income statements, cash flow statements, and balance sheets. The focus is on the most recent four years of data (through Q4 2025) to help retail investors gauge earnings quality, cash generation, and balance-sheet strength. Key trends include solid cash flow in late 2025, a large one-time restructuring hit in Q4 2025, and a generally stable but leveraged balance sheet.

  • Q4 2025 Net Cash From Continuing Operating Activities: $657,100,000
  • Q4 2025 Net Change in Cash & Equivalents: $86,800,000
  • Q4 2025 Free Cash Flow (roughly CFO minus CAPEX): about $630,700,000
  • As of Q3 2025, Total Current Assets were about $5.567B and Total Current Liabilities were about $3.991B, implying roughly $1.576B of working capital
  • Total Assets around $12.079B; Total Liabilities about $8.278B; Total Equity approximately $3.801B as of Q3 2025
  • Long-Term Debt about $3.271B and Short-Term Debt about $1.272B (debt burden in the mid-range for a large cap chemical company)
  • Q4 2025 Revenue was $1.0833B, with Q3 2025 at $0.5422B and Q4 2024 at $1.2243B, indicating some quarter-to-quarter volatility and seasonality
  • Q4 2025 Gross Profit $431.1M on $1.0833B revenue, yielding a margin around the low 40s percent (roughly 40%), broadly in line with recent quarters
  • Q4 2025 Restructuring Charge: $1,611,300,000, contributing to a negative operating result
  • Q4 2025 Net Income Attributable to Common Shareholders: -$1,720,800,000 (reflecting the restructuring and related charges)

Bottom line: FMC’s cash flow generation was positive and sizable in Q4 2025, signaling improving liquidity and potential for future capital deployment. However, the quarter also included a large one-time restructuring charge that drove a substantial hit to earnings. The balance sheet remains solid with adequate liquidity and a manageable debt load, but the elevated long- and short-term debt levels warrant watching as FMC continues to execute its strategic plan. Investors should monitor how ongoing restructuring and cost-reduction efforts influence margins and free cash flow in 2026.

05/20/26 05:51 PM ETAI Generated. May Contain Errors.

FMC Financials - Frequently Asked Questions

According to the most recent income statement we have on file, FMC's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

FMC's net income appears to be on a downward trend, with a most recent value of -$2.24 billion in 2025, falling from $498.50 million in 2015. The previous period was $341.60 million in 2024. See FMC's forecast for analyst expectations on what's next for the company.

FMC's total operating income in 2025 was -$1.63 billion, based on the following breakdown:
  • Total Gross Profit: $1.28 billion
  • Total Operating Expenses: $2.91 billion

Over the last 10 years, FMC's total revenue changed from $2.49 billion in 2015 to $3.47 billion in 2025, a change of 39.2%.

FMC's total liabilities were at $7.59 billion at the end of 2025, a 6.2% increase from 2024, and a 71.8% increase since 2015.

In the past 10 years, FMC's cash and equivalents has ranged from $64.20 million in 2016 to $584.50 million in 2025, and is currently $584.50 million as of their latest financial filing in 2025.

Over the last 10 years, FMC's book value per share changed from 13.96 in 2015 to 16.58 in 2025, a change of 18.8%.



Financial statements for NYSE:FMC last updated on 5/3/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners